Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension (BETTER-HTN).

Trial Profile

Bioimpedance Evaluation of Therapeutic Titration in Essential, Refractory Hypertension (BETTER-HTN).

Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Feb 2017

At a glance

  • Drugs ACE inhibitors; Alpha adrenergic receptor agonists; Angiotensin receptor antagonists; Beta-adrenergic receptor antagonists; Calcium channel antagonists; Dihydropyridines; Loop diuretics; Potassium-sparing diuretics; Thiazide diuretics; Vasodilators
  • Indications Essential hypertension
  • Focus Therapeutic Use
  • Acronyms BETTER-HTN
  • Most Recent Events

    • 17 Jun 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top